Vol. 102, Issue 6
Articles
What Makes Ensuring Access to Affordable Prescription Drugs the Hardest Problem in Health Policy?, by Michelle M. Mello here
Delinking Reimbursement, by Rachel E. Sachs here
Dangerous Times: The FDA’s Role in Information Production, Past and Future, by Amy Kapczynski here
Regulatory Silence at the FDA, by Jordan Paradise here
Drug Approval in a Learning Health System, by W. Nicholson Price II here
The Morality of Compulsory Licensing as an Access to Medicines Tool, by Margo A. Bagley here
Notes
I Get By with a Little Help from My 750-Dollar-Per-Tablet Friends: A Model Act for States to Prevent Dramatic Pharmaceutical Price Increases, by Alexander Walsdorf here